Moderna Outlines Next Phase of Growth at Analyst Day

Highlights intismeran and cancer antigen therapies as foundational opportunities for a growing oncology franchiseDetails commercial and manufacturing readiness for intismeran following positive Phase 3 results in adjuvant melanomaHighlights multiple …